Authors: Bergrem, H Leivestad, T

Citation: H. Bergrem et T. Leivestad, Diabetic nephropathy and end-stage renal failure: The Norwegian story, ADV RENAL R, 8(1), 2001, pp. 4-12

Authors: van Dijk, PCW Jager, KJ de Charro, F Collart, F Cornet, R Dekker, FW Gronhagen-Riska, C Kramar, R Leivestad, T Simpson, K Briggs, JD

Citation: Pcw. Van Dijk et al., Renal replacement therapy in Europe: the results of a collaborative effortby the ERA-EDTA registry and six national or regional registries, NEPH DIAL T, 16(6), 2001, pp. 1120-1129

Authors: Sagedal, S Nordal, KP Hartmann, A Degre, M Holter, E Foss, A Osnes, K Leivestad, T Fauchald, P Rollag, H

Citation: S. Sagedal et al., A prospective study of the natural course of cytomegalovirus infection anddisease in renal allograft recipients, TRANSPLANT, 70(8), 2000, pp. 1166-1174

Authors: Paulsen, D Klow, NE Rogstad, B Leivestad, T Lien, B Vatne, K Fauchald, P

Citation: D. Paulsen et al., Preservation of renal function by percutaneous transluminal angioplasty inischaemic renal disease, NEPH DIAL T, 14(6), 1999, pp. 1454-1461

Authors: Jensen, P Hansen, S Moller, B Leivestad, T Pfeffer, P Geiran, O Fauchald, P Simonsen, S

Citation: P. Jensen et al., Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens, J AM ACAD D, 40(2), 1999, pp. 177-186

Authors: Jensen, P Hansen, S Moller, B Leivestad, T Pfeffer, P Fauchald, P

Citation: P. Jensen et al., Are renal transplant recipients an CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone?, TRANSPLAN P, 31(1-2), 1999, pp. 1120-1120